The PE Ratio as of November 2024 (TTM) for Third Harmonic Bio, Inc. (THRD) is -12.86

According to Third Harmonic Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -12.86. This represents a change of 75.70% compared to the average of -7.32 of the last 4 quarters.

Third Harmonic Bio, Inc. (THRD) Historical PE Ratio (quarterly & annually)

How has THRD PE Ratio performed in the past?

The mean historical PE Ratio of Third Harmonic Bio, Inc. over the last ten years is -23.04. The current -12.86 PE Ratio has changed 5.48% with respect to the historical average. Over the past ten years (40 quarters), THRD's PE Ratio was at its highest in in the September 2024 quarter at 10.14. The PE Ratio was at its lowest in in the June 2022 quarter at -21.73.

Third Harmonic Bio, Inc. (THRD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Third Harmonic Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Third Harmonic Bio, Inc. (THRD) Average PE Ratio

How has THRD PE Ratio performed in the past?

The current PE Ratio of Third Harmonic Bio, Inc. (THRD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Third Harmonic Bio, Inc. (THRD) PE Ratio vs. Peers

How is THRD’s PE Ratio compared to its peers?

Third Harmonic Bio, Inc.’s PE Ratio is less than Sensei Biotherapeutics, Inc. (-0.44), less than NextCure, Inc. (-0.57), less than Nuvation Bio Inc. (-1.44), less than Graphite Bio, Inc. (-0.13), less than Merrimack Pharmaceuticals, Inc. (-8.92), less than Cullinan Oncology, Inc. (-5.10), greater than Edgewise Therapeutics, Inc. (-24.30), less than Rallybio Corporation (-0.68), less than Monte Rosa Therapeutics, Inc. (-5.83), less than PMV Pharmaceuticals, Inc. (-1.61), less than Enochian Biosciences, Inc. (-1.00), greater than Revolution Medicines, Inc. (-16.70), less than Passage Bio, Inc. (-0.45), less than Werewolf Therapeutics, Inc. (-1.34), less than Acrivon Therapeutics, Inc. Common Stock (-3.24), less than Eliem Therapeutics, Inc. (-2.42),

Build a custom stock screener for Third Harmonic Bio, Inc. (THRD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Third Harmonic Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Third Harmonic Bio, Inc. (THRD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Third Harmonic Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.